跨导管三门更换:当前的选择和未来的前景
Guido Del Monaco1,2, Gianluca Mincione1,2, Alessandro Sticchi3,4
1Cardiovascular Department IRCCS (Istituto di Ricerca e Cura a Carattere Scientifico) Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
Reviews in cardiovascular medicine
|January 27, 2025
概括
透导管三管替换 (TTVR) 为严重三管吐 (TR) 患者提供了一个新的选择,这些患者不适合进行手术. 虽然有希望,但长期风险如膜血栓塞和起器需要进一步研究.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 三管吐 (TR) 是一种严重的疾病,治疗选择有限.
- 传统的医疗和手术管理带来了挑战,特别是对于高风险患者.
- 透导管疗法正在为结构性心脏病发展.
研究的目的:
- 评估跨导管三门置换 (TTVR) 作为严重TR的新兴治疗方法.
- 突出TTVR在患有外科手术风险过高的患者中的潜在益处.
- 确定和讨论与TTVR相关的新出现的挑战.
主要方法:
- 审查目前的临床数据和关于TTVR程序的新兴证据.
- 分析受益于跨导管干预的患者群体.
- 确定未来研究和临床监测的关键领域.
主要成果:
- 在不同的解剖学和患者群体中,TTVR显示了积极的临床结果.
- 透导管方法为手术风险较高的患者提供了替代方案.
- 新出现的担忧包括长期的门耐用性,血栓形成风险和心脏起器植入率.
结论:
- 对于严重的TR,TTVR是一种可行的,不断发展的治疗选择.
- 对长期安全性和有效性的进一步研究至关重要.
- 解决门耐用性和程序性并发症等挑战将加强TTVR的采用.
更多相关视频
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


